X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Johnson & Johnson Announces Development Of Zika Vaccine

Yuvraj_pawp by Yuvraj_pawp
6th December 2017
in Research & Development

Johnson & Johnson announced that Janssen Vaccines & Prevention BV, part of the Janssen Pharmaceutical Companies, is working in partnership with the Beth Israel Deaconess Medical Center (BIDMC), the United United States, to validate and accelerate the development of a vaccine against the Zika virus. In addition to the scientific effort, Janssen Brasil presents the results of the Zikalab project, held in the country since 2016, to train public health professionals who are at the forefront of providing care to the population in the areas most affected by the virus.

The news will be presented during the Brazilian premiere of the documentary Unseen Enemy (“Enemy Invisible”), supported by the company, which alerts the global community about the risk of new pandemics caused by viruses such as Zika, Influenza and Ebola. The release takes place on December 5, in Recife , where the recording was performed on Zika.

In partnership with the National Council of Municipal Health Secretaries (CONASEMS) and the Institute for Research and Support to Social Development (IPADS), Zikalab has trained about 7,000 health professionals in 37 municipalities in six states (Pernambuco, Pernambuco , Bahia, Mato Grosso , Minas Gerais, Tocantins and Paraíba), focusing on prevention and care for pregnant women, mothers and babies with microcephaly.

“The outbreak of the Zika virus has profoundly affected families and the health system in Brazil and has required a rapid and intense mobilization of all sectors of society.The Zikalab is an example of how collaboration between various institutions, whether public or private, can positively impact public health challenges, “says Bruno Costa Gabriel , president of Janssen Brazil . “Training enables health professionals to be empowered and prepared to respond to the threat of the virus,” says Fernanda Pimentel , Johnson & Johnson’s chief medical officer for Latin America. So far, the company has invested around R $ 2.3 million in support to the country in coping with the disease.

In addition to this collaboration, Janssen makes every effort to find an immunizer against Zika through its innovative AdVac® platform that enables faster development of a variety of vaccine candidates based on adenovirus vectors for a range of diseases . Tested by the BIDMC, the vaccine provided, at an early stage, the second preclinical study, complete protection against Zika following a single primate immunization, making it a promising candidate for testing in humans.

“Our partnership with BIDMC unites the brightest scientific minds and the latest technologies in an effort to develop the vaccine,” explains Paul Stoffels , Johnson’s Chief Scientific Officer.

Another example of scientific exchange was the support to studies of the Federal University of Rio de Janeiro (UFRJ-COPPE) on the Zika virus in 2016. For the first time, a Brazilian project won a challenge from JLabs – incubator network of the innovation platform Johnson & Johnson. For six months, researcher Leda Castilho and her team had access to state-of-the-art labs, mentoring, and cutting-edge infrastructure to accelerate their research.

Previous Post

Hitachi Medical Systems Europe Introduces "LISENDO 880", th New Premium 2D/4D CARDIOVASCULAR Ultrasound System

Next Post

Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

Related Posts

Tumors Can Get Destroyed By Bacteria-Aid To Immune System
News

Tumors Can Get Destroyed By Bacteria-Aid To Immune System

16th March 2023
News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Featured

Animal Testing Could See An End With An Artificial Model

28th February 2023
Featured

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

27th February 2023
Next Post
Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In